There's Been No Shortage Of Growth Recently For Nature's Sunshine Products' (NASDAQ:NATR) Returns On Capital




  • In Business
  • 2023-01-01 14:17:15Z
  • By Simply Wall St.
 

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically, we'll want to notice a trend of growing return on capital employed (ROCE) and alongside that, an expanding base of capital employed. Put simply, these types of businesses are compounding machines, meaning they are continually reinvesting their earnings at ever-higher rates of return. So on that note, Nature's Sunshine Products (NASDAQ:NATR) looks quite promising in regards to its trends of return on capital.

Understanding Return On Capital Employed (ROCE)

If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. The formula for this calculation on Nature's Sunshine Products is:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.12 = US$20m ÷ (US$224m - US$64m) (Based on the trailing twelve months to September 2022).

So, Nature's Sunshine Products has an ROCE of 12%. In absolute terms, that's a pretty normal return, and it's somewhat close to the Personal Products industry average of 14%.

See our latest analysis for Nature's Sunshine Products

In the above chart we have measured Nature's Sunshine Products' prior ROCE against its prior performance, but the future is arguably more important. If you'd like to see what analysts are forecasting going forward, you should check out our free report for Nature's Sunshine Products.

So How Is Nature's Sunshine Products' ROCE Trending?

Nature's Sunshine Products has not disappointed with their ROCE growth. More specifically, while the company has kept capital employed relatively flat over the last five years, the ROCE has climbed 608% in that same time. Basically the business is generating higher returns from the same amount of capital and that is proof that there are improvements in the company's efficiencies. On that front, things are looking good so it's worth exploring what management has said about growth plans going forward.

The Key Takeaway

To bring it all together, Nature's Sunshine Products has done well to increase the returns it's generating from its capital employed. Given the stock has declined 23% in the last five years, this could be a good investment if the valuation and other metrics are also appealing. With that in mind, we believe the promising trends warrant this stock for further investigation.

If you want to continue researching Nature's Sunshine Products, you might be interested to know about the 1 warning sign that our analysis has discovered.

If you want to search for solid companies with great earnings, check out this free list of companies with good balance sheets and impressive returns on equity.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You'll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here

COMMENTS

More Related News

Denbury (NYSE:DEN) Is Very Good At Capital Allocation
Denbury (NYSE:DEN) Is Very Good At Capital Allocation

There are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...

Be Wary Of Cognex (NASDAQ:CGNX) And Its Returns On Capital
Be Wary Of Cognex (NASDAQ:CGNX) And Its Returns On Capital

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. One common...

Atlantic Navigation Holdings (Singapore) (Catalist:5UL) Is Experiencing Growth In Returns On Capital
Atlantic Navigation Holdings (Singapore) (Catalist:5UL) Is Experiencing Growth In Returns On Capital

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

These Return Metrics Don
These Return Metrics Don't Make Stamford Land (SGX:H07) Look Too Strong

What financial metrics can indicate to us that a company is maturing or even in decline? More often than not, we'll see...

Investors Will Want Myer Holdings
Investors Will Want Myer Holdings' (ASX:MYR) Growth In ROCE To Persist

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

  • 바카라
    (2023-01-02 11:37:44Z)

    Wow! This could be one particular of the most beneficial blogs We’ve ever arrive across on this subject. Basically Excellent. I’m also a specialist in this topic therefore I can understand your hard work.

    REPLY
  • mack jahny
    (2023-01-18 05:47:43Z)

    Muchas gracias por este maravilloso escrito. Me interesan mucho tus publicaciones y me ayudan mucho. Sigue haciendo el gran trabajo. Seguro que siempre estaré pendiente de tus trabajos, gracias.

    REPLY
  • Annemnani
    (2023-01-29 02:44:32Z)

    9 g received 0 purchasing cialis online One of the best characterized models of human presbycusis is the Mongolian gerbil 2, 20, 21, 81, 97, 206, 208, 300, 301, 341

    REPLY
  • Juguetes didácticos
    (2023-01-30 14:19:57Z)

    This was really an interesting topic and I kinda agree with what you have mentioned here!

    REPLY
  • TubeMate
    (2023-02-02 08:46:15Z)

    I haven’t any word to appreciate this post.....Really i am impressed from this post....the person who create this post it was a great human..thanks for shared this with us.

    REPLY
  • Annemnani
    (2023-02-02 12:30:37Z)

    Antitumor and anticancer stem cell activities of eribulin mesylate and antiestrogens in breast cancer cells clomid 100 mg

    REPLY
  • lista de editoriales para publicar
    (2023-02-06 18:12:46Z)

    I appreciated your work very thanks

    REPLY

Top News: Business